Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
AD     Remove this Ad

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 20.797.03-63.65475.4870.50

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 20.79 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202520.79
Mar20247.03
Mar2023-63.65
Mar2022475.48
Mar202170.50

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 20.79
195.73
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48
574.44
Mar2021 70.5 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹1,494.9 Cr -1.1% 34.3% 92.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-1.1%

34.3%

92.4%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses